The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NGS-based molecular panel analysis of metastatic prostate cancer for daily routine: How often do we detect druggable mutations?
 
Olivia Steenbock
No Relationships to Disclose
 
Constantin Rieger
Speakers' Bureau - Medac
 
Julian Heidenreich
No Relationships to Disclose
 
Pia Paffenholz
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Ipsen; Janssen; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
David Pfister
No Relationships to Disclose
 
Richard Weiten
No Relationships to Disclose
 
Melanie von Brandenstein
No Relationships to Disclose
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - BMS Oncology